Taiwan recalls hypothyroidism drug over low active ingredient levels

Taiwan's Food and Drug Administration (FDA) has ordered the recall of two batches of a medication used to treat hypothyroidism after stability tests found its active ingredient levels had fallen below standard, potentially reducing the drug's effectiveness, an FDA official said Thursday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)